A vast number of compounds identified through these methods have already made significant strides in treating diseases such as viral infections and cancer, including HIV inhibitors, tyrosine kinase inhibitors for chronic myeloid leukemia, and ALK inhibitors for pancreatic cancer, among others [[34], [35], [36], [37]]. This evidence concerns the gene ALK and pancreatic neoplasm.